Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Naproxen"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringNaproxen (sodium; free acid)
brandStringAleve (OTC), Naprosyn (Rx), Anaprox (Rx), Naprelan (ER), EC-Naprosyn (enteric-coated), Vimovo (with esomeprazole)
structureFile
classesList of String, delimiter: ,[[:Category:NSAIDs|Non-steroidal anti-inflammatory (NSAID)]] [[:Category:Analgesics|Analgesic]] [[:Category:Antipyretics|Antipyretic]]
mechanismString
usesString'"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"', '"`UNIQ--vote-00000026-QINU`"', '"`UNIQ--vote-00000027-QINU`"', '"`UNIQ--vote-00000028-QINU`"'
starting_doseStringOTC: 220 mg PO every 8-12 hours, max 660 mg/24h. Rx: 250-500 mg PO BID. Acute gout: 750 mg loading then 250 mg every 8 hours
preparationsStringOTC tablets 220 mg; Rx tablets 250, 375, 500 mg; ER tablets 375, 500, 750 mg (Naprelan); oral suspension 125 mg/5 mL; enteric-coated tablets (EC-Naprosyn)
fda_maxString1500 mg/day (Rx); 660 mg/24h (OTC, without provider direction)
pill_idText
routesList of String, delimiter: ,Oral
onsetString30-60 minutes
durationString8-12 hours (the long-duration feature relative to ibuprofen)
halflifeString12-17 hours'"`UNIQ--ref-00000029-QINU`"'
bioavailabilityString~95% (oral)'"`UNIQ--ref-0000002A-QINU`"'
pregnancyStringAvoid from 20 weeks gestation onward per FDA's 2020 expanded NSAID warning (fetal renal dysfunction, oligohydramnios); contraindicated from 30 weeks (risk of premature ductus arteriosus closure)'"`UNIQ--ref-0000002B-QINU`"'
legalString[[USLegal:Over-the-counter|OTC]] in US at ≤220 mg/tablet and ≤660 mg/day; [[USLegal:Prescription only|Rx-only]] at higher strengths